A pharmaceutical composition for treating non-alcoholic fatty liver diseases consists of a silybin-phospholipid compound preparation and Pu'er tea/tea product according to a weight ratio of 0.5-2.5:0.3-10, wherein the silybin-phospholipid compound capsule preparation and the Pu'er tea/tea product are separately packaged.
